Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common cause of cardiovascular mortality and morbidity. Patients undergoing major orthopaedic surgery, including hip and knee arthroplasty, represent a group that is at particularly high risk for VTE, especially patients with risk factors (age >60 years, cancer, prior VTE).
AllenC, GlasziouP, Del MarC1999Bed rest: a potentially harmful treatment needing more careful evaluationLancet354(9186) 1229–33
2.
Amaragiri2001Elastic compression stockings for prevention of deep vein thrombosis (Cochrane Review)
3.
Antiplatelet Trialists' Collaboration1994Collaborative overview of randomised trials of antiplatelet therapy–III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients.Antiplatelet Trialists' Collaboration BMJ308(6923) 235–46
4.
BrookenthalKR, FreedmanKB, LotkePA, FitzgeraldRH, LonnerJH2001A meta-analysis of thromboembolic prophylaxis in total knee arthroplastyJ Arthroplasty16(3) 293–300
5.
ColwellCWJr, CollisDK, PaulsonR, McCutchenJW, BiglerGT, LutzS, HardwickME1999Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty.Evaluation during hospitalization and three months after discharge J Bone Joint Surg Am81(7) 932–40
CusickLA, BeverlandDE2009The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patientsJ Bone Joint Surg Br91(5) 645–8
8.
ErikssonBI, BorrisLC, FriedmanRJ, HaasS, HuismanMV, KakkarAK, BandelTJ, BeckmannH, MuehlhoferE, MisselwitzF, GeertsW2008Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplastyN Engl J Med358(26) 2765–75
9.
ErikssonBI, DahlOE, RosencherN, KurthAA, vanDijk CN, FrostickSP, KaleboP, ChristiansenAV, HantelS, HettiarachchiR, SchneeJ, BullerHR2007Oral dabigatran etexilate vs.subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial J Thromb Haemost5(11) 2178–85
10.
ErikssonBI, DahlOE, RosencherN, KurthAA, vanDijk CN, FrostickSP, PrinsMH, HettiarachchiR, HantelS, SchneeJ, BullerHR2007Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trialLancet370(9591) 949–56
11.
FrancisCW, PellegriniVDJr., TottermanS, BoydADJr., MarderVJ, LiebertKM, StulbergBN, AyersDC, RosenbergA, KesslerC, JohansonNA1997Prevention of deep-vein thrombosis after total hip arthroplasty.Comparison of warfarin and dalteparin J Bone Joint Surg Am79(9) 1365–72
12.
GeertsWH, BergqvistD, PineoGF, HeitJA, SamamaCM, LassenMR, ColwellCW2008Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest133(6 Suppl) 381S–453S
13.
GinsbergJS, DavidsonBL, CompPC, FrancisCW, FriedmanRJ, HuoMH, LiebermanJR, MuntzJE, RaskobGE, ClementsML, HantelS, SchneeJM, CapriniJA2009Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgeryJ Arthroplasty24(1) 1–9
14.
GoelDP, BuckleyR, deVriesG, AbelsethG, NiA, GrayR2009Prophylaxis of deep-vein thrombosis in fractures below the knee: a prospective randomised controlled trialJ Bone Joint Surg Br91(3) 388–94
15.
HeitJA, SilversteinMD, MohrDN, PettersonTM, LohseCM, O'FallonWM, MeltonLJ3rd2001The epidemiology of venous thromboembolism in the communityThromb Haemost86(1) 452–63
16.
ImperialeTF, SperoffT1994A meta-analysis of methods to prevent venous thromboembolism following total hip replacementJAMA271(22) 1780–5
17.
JohnsonR, CarmichaelJH, AlmondHG, LoynesRP1978Deep venous thrombosis following Charnley arthroplastyClin Orthop Relat Res (132) 24–30
18.
KakkarAK, BrennerB, DahlOE, ErikssonBI, MouretP, MuntzJ, SoglianAG, PapAF, MisselwitzF, HaasS2008Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trialLancet372(9632) 31–9
19.
LassenMR, RaskobGE, GallusA, PineoG, ChenD, HornickP2010Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trialLancet375(9717) 807–15
20.
LassenMR, RaskobGE, GallusA, PineoG, ChenD, PortmanRJ2009Apixaban or enoxaparin for thromboprophylaxis after knee replacementN Engl J Med361(6) 594–604
21.
LotkePA, PalevskyH, KeenanAM, MeranzeS, SteinbergME, EckerML, KelleyMA1996Aspirin and warfarin for thromboembolic disease after total joint arthroplastyClin Orthop Relat Res (324) 251–8
22.
LassenMR, AgenoW, BorrisLC, LiebermanJR, RosencherN, BandelTJ, MisselwitzF, TurpieAG2008Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplastyN Engl J Med358(26) 2776–86
23.
NICE2007Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgeryLondon, NICE
24.
NicolaidesAN, BreddinHK, FareedJ, GoldhaberS, HaasS, HullR, KalodikiE, MyersK, SamamaM, SasaharaA2001Prevention of venous thromboembolism. International Consensus Statement.Guidelines compiled in accordance with the scientific evidence Int Angiol20(1) 1–37
25.
PalmerAJ, KoppenhagenK, KirchhofB, WeberU, BergemannR1997Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trialsHaemostasis27(2) 75–84
26.
PEP2000Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trialLancet355(9212) 1295–302
27.
PlanesA, VochelleN, DarmonJY, FagolaM, BellaudM, HuetY1996Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placeboLancet348(9022) 224–8
28.
PorteousMJ, NicholsonEA, MorrisLT, JamesR, NegusD1989Thigh length versus knee length stockings in the prevention of deep vein thrombosisBr J Surg76(3) 296–7
29.
RandelliP, CastagnaA, CabitzaF, CabitzaP, ArrigoniP, DentiM2010Infectious and thromboembolic complications of arthroscopic shoulder surgeryJ Shoulder Elbow Surg19(1) 97–101
30.
RodgersA, WalkerN, SchugS, McKeeA, KehletH, van ZundertA, SageD, FutterM, SavilleG, ClarkT, MacMahonS2000Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trialsBMJ321(7275) 1493
31.
RogersB, LittleN, JonesC2009Monitoring and management of heparin-induced thrombocytopeniaBr J Hosp Med (Lond)70(11) 630–3
TurpieAG, LassenMR, DavidsonBL, BauerKA, GentM, KwongLM, CushnerFD, LotkePA, BerkowitzSD, BandelTJ, BensonA, MisselwitzF, FisherWD2009Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trialLancet373(9676) 1673–80
34.
WarwickD2004New concepts in orthopaedic thromboprophylaxisJ Bone Joint Surg Br86(6) 788–92
35.
WarwickD, FriedmanRJ, AgnelliG, Gil-GarayE, JohnsonK, FitzGeraldG, TuribioFM2007Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic RegistryJ Bone Joint Surg Br89(6) 799–807
